8 Epstein-Barr virus as an agent of haematological disease

Bailliere's Clinical Haematology

Volumn 8, Issue 1, 1995, Pages 165-199

  Tosato, Giovanna ^a   Taga, Kazuyuki ^a   Angiolillo, Anne L ^a   Sgadari, Cecilia ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BURKITT LYMPHOMA; CELLULAR IMMUNITY; EPSTEIN BARR VIRUS; HEMATOLOGIC DISEASE; HODGKIN DISEASE; INFECTIOUS MONONUCLEOSIS; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; NATURAL KILLER CELL; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; VIRUS IMMUNITY; VIRUS INFECTION; VIRUS LATENCY; VIRUS REPLICATION;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CHILD; FEMALE; GENOME, VIRAL; HEMATOLOGIC DISEASES; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HUMAN; INFECTIOUS MONONUCLEOSIS; LYMPHOMA; LYMPHOPROLIFERATIVE DISORDERS; MALE; POSTOPERATIVE COMPLICATIONS; SALIVA; TRANSPLANTATION; TUMOR VIRUS INFECTIONS; VIRAL PROTEINS; VIRUS LATENCY; VIRUS REPLICATION;

EID: 0028965648     PISSN: 09503536     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3536(05)80237-9     Document Type: Article

References (312)

1. Human B-lymphotropic virus (human herpesvirus-6)
2. Burkitt's lymphoma in Algeria
3. Dental tissues and Burkitt's tumor
4. Primary infection by Epstein-Barr virus presenting as aplastic anemia
5. The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory
6. A putative transforming gene of jijoye virus differs from that of Epstein-Barr virus prototypes
7. Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-1 positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization
8. DNA sequence and expression of the B95-8 Epstein-Barr virus genome
9. Posttranslational processing of an Epstein-Barr virus-encoded membrane protein expressed in cells transformed by Epstein-Barr virus
10. Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus
11. Penicillin-related exanthems in infectious mononucleosis identical to those associated with ampicillin
12. Multiple genetic lesions in AIDS related non-Hodgkin lymphoma
13. Epstein-Barr virus in the bone marrow of patients with aplastic anemia
14. The serological diagnosis of glandular fever (infectious mononucleosis): a new technique
15. Clinical complications
16. Cytogenic studies on African Burkitt's lymphoma cell lines; t(8;14), t(2;8) and t(8;22) translocations
17. Lymphomas and lymphoproliferative lesions developing under cyclosporin therapy
18. Human herpesvirus-6 (HHV-6, HBLV) in sarcoidosis and lymphoproliferative disorders
19. Lymphoma in cardiac transplant recipients associated with cyclosporin A, prednisone and anti-thymocyte globulin
20. Presenting Clinical Features of Burkitt's Lymphoma in Ghana, West Africa
21. Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders
22. Treatment of severe Epstein-Barr virus-induced polyclonal B-lymphocyte proliferation by anti-B-cell monoclonal antibodies. Two cases after HLA-mismatched bone marrow transplantation
23. Lymphoma of host origin in a marrow transplant recipient in remission of acute myeloid leukemia and receiving cyclosporin A
24. Severe chronic EBV infection associated with specific EBV immunodeficiency and an EBNA + T-cell lymphoma containing linear, EBV DNA
25. Burkitt's lymphoma: a model for clinical oncology
26. Limiting-dilution analysis of the HLA restriction of anti-Epstein-Barr virus-specific cytolytic T lymphocytes
27. Auto-anti-N immunohemolytic anemia in infectious mononucleosis
28. Subtypes of Epstein-Barr virus (EBV) in Hodgkin's disease: association between B-type EBV and immunocompromise
29. Epstein-Barr virus, cytomegalovirus, and other viral infections in children after liver transplantation
30. Immunoregulation during acute infection with Epstein-Barr virus: dynamics of interferon and 2′,5′-oligoadenylate synthetase activity
31. Glandular fever. A study of a hospital series in Sydney
32. Demonstration of Epstein-Barr virus replication in Reed-Sternberg cells of Hodgkin's disease
33. Determining the climatic limitations of a childrens' cancer common in Africa
34. General features and facial tumours
35. Geographical distribution
36. An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3)
37. An Epstein-Barr virus-specific cytotoxic T-cell epitope present on A and B-type transformants
38. Studies on infectious mononucleosis. IV. Changes in the granulocyte series
39. Granulocyte in infectious mononucleosis
40. Thrombocytopenic purpura in infectious mononucleosis
41. Antibody to herpesvirus hominis types 1 and 2 in patients with Hodgkin's disease and carcinoma of the nasopharynx
42. Evidence for restricted Epstein-Barr virus latent gene expression and anti-EBNA antibody response in solid organ transplant recipients with posttransplant lymphoproliferative disorders
43. Specific translocations characterize Burkitt's-like lymphoma of homosexual men with the acquired immunodeficiency syndrome
44. Intense jaundice in an adolescent. An unusual presentation of infectious mononucleosis
45. Detection of clonal Epstein-Barr virus in malignant proliferation of peripheral blood CD3+ CD8+ T cells
46. Fatal infectious mononucleosis: Association with liver necrosis and Herpes-like virus particles
47. Infectious mononucleosis: The classic clinical syndrome
48. Infectious mononucleosis. The spectrum of morphologic changes simulating lymphoma in lymph nodes and tonsils
49. Polyclonal lymphoma confined to renal allograft: case report
50. The seroepidemiology of human herpesvirus-6 (HHV-6) from a case control study of leukaemia and lymphoma
51. Monoclonality of lymphoproliferative lesions in cardiac-transplant recipients. Clonal analysis based on immunoglobulin-gene rearrangements
52. Epstein-Barr virus lymphoproliferative disease associated with acquired immunodeficiency
53. Effect of acyclovir [9-(2-hydroxyethoxymethyl)guanine]on Epstein-Barr virus DNA replication
54. Activation of expression of latent Epstein-Barr herpes-virus after gene transfer with a small cloned subfragment of heterogeneous viral DNA
55. Molecular biology of lymphomas
56. Human c-myc oncogene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells
57. Expression of the Epstein-Barr virus nuclear protein 2 in rodent cells
58. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells
59. Characterization of immunoregulatory T cells in EBV-induced infectious mononucleosis by monoclonal antibodies
60. Demonstration of a herpes group virus in cultures of peripheral leukocytes from patients with infectious mononucleosis
61. Childhood lymphosarcoma in St. Louis, Missouri, clinically and histologically resembling Burkitt's lymphoma
62. Expression of B-cell surface markers in different Burkitt lymphoma subgroups
63. T and B cells in the peripheral blood during infectious mononucleosis
64. Infectious mononucleosis in University of Wisconsin students: report of a five-year investigation
65. A population-based case-control study of EBV and other viral antibodies among persons with Hodgkin's disease and their siblings
66. Seroepidemiologic studies of infectious mononucleosis with EB virus
67. A prospective evaluation of heterophile and Epstein-Barr virus-specific IgM antibody tests in clinical and subclinical infectious mononucleosis: Specificity and sensitivity of the tests and persistence of antibody
68. Epstein-Barr virus infections in Brazil. II. Hodgkin's disease
69. Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus
70. Expression of Epstein-Barr virus-encoded proteins and B-cell markers in fatal infectious mononucleosis
71. Distinct reactivity of Burkitt's lymphoma cell lines with eight monoclonal antibodies correlated with the ethnic origin
72. Lektush ob Ostriku Infektsion Nikh Lolieznyak
73. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2
74. Characterization of a T-lymphocyte Epstein-Barr virus/C3 Receptor (CD21)
75. Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation
76. Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients
77. A mechanism of T cell regulation of Epstein-Barr virus latency
78. Primary Epstein-Barr virus infection with clonal T-cell lymphoproliferation
79. Association of EB-virus infection with the post-perfusion syndrome
80. TRANSFORMATION AND CHROMOSOME CHANGES INDUCED BY EPSTEIN-BARR VIRUS IN NORMAL HUMAN LEUKOCYTE CULTURES
81. Novel transcription from the Epstein-Barr virus terminal EcoRI fragment, DIJhet, in a nasopharyngeal carcinoma
82. Expression of the Epstein-Barr virus BamHI A fragment in nasophrayngeal carcinoma: evidence for a viral protein expressed in vivo
83. Viral involvement in Hodgkin's disease: detection of clonal type A EBV genomes in tumour samples
84. Leukocyte-transforming agent: prolonged excretion by patients with mononucleosis and excretion by normal individuals
85. Soluble factor requirements for the autostimulatory growth of B lymphoblasts immortalized by EBV
86. Epstein-Barr virus binding sites in lymphocyte subpopulations and the origin of lymphoblasts in cultured lymphoid cell lines and in the blood of patients with infectious mononucleosis
87. Different Epstein-Barr virus (EBV)-B cell interactions in phenotypically distinct clones of a Burkitt lymphoma cell line
88. Epstein-Barr virus infections in males with the X-linked lymphoproliferative syndrome
89. Pathogenesis of B-cell lymphoma in a patient with AIDS
90. Neurological complication of infectious mononucleosis
91. Surface immunoglobulins on Burkitt's lymphoma biopsy cells from 91 patients
92. AIDS-related lymphoma: Histopathology, immunophenotype, and association with EBV as demonstrated by in situ nucleic acid hybridization
93. Severe neutropenia in infectious mononucleosis
94. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus
95. Epstein-Barr virus induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation
96. Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation
97. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma
98. Immune deficiency in the X-linked lymphoproliferative syndrome. I. Epstein-Barr virus-specific defects
99. Epstein-Barr viral DNA in acute large granular lymphocyte (natural killer) leukemic cells
100. Case-control study of Hodgkin's disease. II. Herpesvirus group antibody titers and HLA type
101. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death
102. Observations on childhood infections with the Epstein-Barr virus
103. Epstein-Barr virus related serology in Hodgkin's disease
104. The immunological approach to study of possible virus-induced human malignancies using the Epstein-Barr virus as example
105. Relation of Burkitt's tumor-associated herpes-type virus to infectious mononucleosis
106. Epstein-Barr virus-specific diagnostic tests in infectious mononucleosis
107. Antibodies to Epstein-Barr virus nuclear antigen in infectious mononucleosis
108. Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells
109. Epstein-Barr virus DNA and latent gene products in Ki-1 (CD30)-positive anaplastic large cell lymphoma
110. A case control study on immunity to two Epstein-Barr virus-associated antigens, and to herpes simplex virus and adenovirus in a population-based group of patients with Hodgkin's disease in Denmark
111. EBV gene expression in an NPC-related tumour
112. Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection
113. The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children
114. Presence of Epstein-Barr virus DNA in nasal lymphomas of ‘B’ and ‘T’ cell type
115. Long-term serological follow-up of patients for Epstein-Barr virus after recovery from infectious mononucleosis
116. Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1
117. Acquired immunodeficiency syndrome associated lymphomas: Clinical, pathological, immunologic and viral characteristics of 111 cases
118. Clonal T-cell lymphoproliferation containing Epstein-Barr (EB) virus DNA in a patient with chronic active EB virus infection
119. The malignant lymphomas in Africa
120. Surgical resection and limited chemotherapy for abdominal undifferentiated lymphomas
121. Hodgkin's disease
122. Infectious mononucleosis: an unsuspected source of anti-i
123. T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections
124. Epstein-Barr virus burden in Hodgkin's disease is related to latent membrane protein gene expression but not to active viral replication
125. Heterophile antigens and antibodies in medicine
126. AIDS-associated non-Hodgkin's lymphoma in San Francisco
127. Simultaneous presence of EBNA-positive and colony-forming cells in peripheral blood of patients with infectious mononucleosis
128. Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative diseases
129. CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA
130. Agranulocytosis Following Infectious Mononucleosis
131. Epstein-Barr virus and its replication
132. Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease
133. Immunological control of human lymphoma: discussion
134. Lymphoma development in mice and humans: diversity of initiation is followed by convergent cytogenetic evolution.
135. Viral latency and transformation: the strategy of Epstein-Barr virus
136. Epstein-Barr virus-carrying cells in Hodgkin's disease
137. AIDS-associated malignant lymphoma
138. Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS): The New York University Medical Center Experience with 105 patients (1981–1986)
139. Molecular genetic analysis of three AIDS associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of the Epstein-Barr virus
140. Immortalization of B lymphocytes by Epstein-Barr virus: what does the virus contribute to the cell?
141. The oncogenic potential of Epstein-Barr virus
142. Antibodies to Epstein-Barr virus, cytomegalovirus, and Australia antigen in Hodgkin's disease
143. Human immunodeficiency virus induction of malignant transformation in human B lymphocytes
144. Aplastic anemia complicating infectious mononucleosis: A case report and review of the literature
145. Replication of EBV in epithelial cells during infectious mononucleosis
146. Burkitt's lymphoma, a human cancer model for the study of the multistep development of cancer: proposal for a new scenario
147. Acquired immunodeficiency syndrome-related lymphoma
148. Development of B-cell lymphoma in homosexual men
149. Retrovirus and malignant lymphomas in homosexual men
150. HIV-related lymphoma: Prognostic factors predictive of survival
151. Elevated antibody titers to Epstein-Barr virus in Hodgkin's disease
152. Epstein-Barr virus infection and replication in a human epithelial cell system
153. Blood and bone marrow in infectious mononucleosis
154. Precision of genotyping of Epstein-Barr virus by polymerase chain reaction using three gene loci (EBNA-2, EBNA-3C, and EBER): predominance of type A virus associated with Hodgkin's disease
155. Immune deficiency in the X-linked lymphoproliferative syndrome. II. Immunoregulatory T cell defects
156. Absence of allogeneic restriction in human T-cell-mediated cytotoxicity to Epstein-Barr virus-infected target cells. Demonstration of an HLA-linked control at the effector level
157. Chronic lymphoproliferative disorders. Classification and diagnosis
158. Regulation of Epstein-Barr virus infection by recombinary interferon-gamma
159. AIDS-related lymphoid neoplasia: The Memorial Hospital experience
160. Epstein-Barr virus in AIDS-related primary central nervous system lymphoma
161. Burkitt's lymphoma as a human tumor model; new concepts in etiology and pathogenesis
162. Pathogenesis of Burkitt's lymphoma
163. African Burkitt's lymphoma
164. Bone marrow involvement in Burkitt's lymphoma and its relationship to acute B cell leukemia
165. Intracerebral Burkitt's lymphoma; pathology, clinical features and treatment
166. The hematologic response
167. Posttranslational processing of the Epstein-Barr virus encoded p63/LMP protein
168. Marker bank in one chromosome 14 from Burkitt lymphomas
169. Alternative involvement of two cytogenetically distinguishable break-points on chromosome 8 in Burkitt's lymphoma associated translocations
170. Transcriptionally active c-myc oncogene is contained within NIARD, a DNA sequence associated with chromosome translocations in B-cell neoplasia
171. Anginose type of infectious mononucleosis requiring tracheostomy
172. Atypical infectious mononucleosis with bone marrow granulomas and pancytopenia
173. Evidence for molecular subtypes of HIV-associated lymphoma: division into peripheral monoclonal, polyclonal and central nervous system lymphoma
174. Epstein-Barr virus: biology, pathogenesis, and medical aspects
175. The switch between latency and replication of Epstein-Barr virus
176. Expression of CD45RO (UCHL1) by CD4+ and CD8+ T cells as a sign of in vivo activation in infectious mononucleosis
177. Interleukin-10
178. Site of Epstein-Barr virus replication in the oropharynx
179. Immunohistological studies of lymphoproliferative lesions in a fatal case of Epstein-Barr virus infection
180. Monoclonal proliferation of T cells containing Epstein-Barr virus in fetal mononuclesis
181. T lymphocytes in infectious mononucleosis. I. T cell death in vitro
182. Thymic lesions in fatal infectious mononucleosis
183. Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis
184. Cyclosporin A immunosuppression, Epstein-Barr antibody, and lymphoma
185. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporin A-prednisone immunosuppression
186. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas. Summary and description of a working formulation for clinical usage
187. Infectious mononucleosis: death due to agranulocytosis and pneumonia
188. Epstein-Barr virus infection precedes clonal expansion in Burkitt's and acquired immunodeficiency associated lymphoma
189. Clinical features of Burkitt's lymphoma; the African experience
190. Epstein-Barr virus antibody in cases and contacts of infectious mononucleosis; a family study
191. Childhood lymphoma resembling Burkitt's lymphoma in the United States
192. Epstein-Barr virus and human diseases: recent advances in diagnosis
193. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease
194. T and B subpopulations in infectious mononucleosis
195. Infusions of donor leukocytes as treatment of Epstein-Barr virus associated lymphoproliferative disorders complicating allogeneic marrow transplantation
196. Cytotoxic effector cells from infectious mononucleosis patients in the acute phase do not specifically kill Epstein-Barr virus genome-carrying lymphoid cell lines
197. Infectious mononucleosis: The humoral response
198. Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma
199. Multiple monoclonal B-cell expansions and c-myc oncogene rearrangements in AIDS-related lymphoproliferative disorders: implications for lymphomagenesis
200. Disseminated intravascular coagulation and hepatic necrosis. Complications of infectious mononucleosis
201. Cancers following cyclosporine therapy
202. Cancers after cyclosporine therapy
203. Treatment of severe Epstein-Barr virus-induced lymphoproliferative syndrome with ganciclovir: Two cases after solid organ transplantation
204. Development of non-Hodgkin's lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on long-term antiretroviral therapy
205. Variable phenotypic expression of an X-linked recessive lymphoproliferative syndrome
206. Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by clinical, virological, and immunopathological studies
207. Epstein-Barr virus-induced diseases in boys with the X-linked lymphoproliferative syndrome (XLP): update on studies of the registry
208. Histopathologic features of high grade non-Hodgkin's lymphomas in acquired immunodeficiency syndrome
209. Infectious mononucleosis and the Epstein-Barr virus
210. Changing concepts in the classification of the hematopoietic system
211. Sequence specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region
212. Molecular analysis of Burkitt's leukemia in two hemophilic brothers with AIDS
213. The cellular basis for viral-induced immunodeficiency: analysis by monoclonal antibodies
214. Epstein-Barr virus in a CD8— positive T-cell lymphoma
215. Cellular immunological responses to the virus infection
216. Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus transformed B cells
217. Plasmacytic differentiation of circulating Epstein-Barr virus-infected B lymphocytes during acute infectious mononucleosis
218. Quantiative evaluation of Epstein-Barrvirus-infected mononuclear peripheral blood leukocytes in infectious mononucleosis
219. Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro
220. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma
221. Disinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins
222. Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man
223. Rupture of the spleen in infectious mononucleosis: a critical review
224. Antibody responses to Epstein-Barr virus in families with the X-linked lymphoproliferative syndrome
225. Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen-1 transcription initiation site
226. Jaw involvement in American Burkitt's lymphoma
227. Aplastic anemia complicating infectious mononucleosis
228. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes.
229. Epstein-Barr virus (infectious mononucleosis)
230. Antineutrophil antibodies in infectious mononucleosis
231. Chronic Epstein-Barr virus infection associated with fever and interstitial pneumonitis. Clinical and serologic features and response to antiviral chemotherapy
232. Expression of Epstein-Barr virus nuclear antigens 3, 4, and 6 are altered in cell lines containing B-type virus
233. Epstein-Barr virus selective T cells in infectious mononucleosis are not restricted to HLA-A and B antigens
234. Molecular genetic analysis of post-transplant lymphoproliferative disorders
235. Aplastic anemia following infectious mononucleosis: Possible immune etiology
236. Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation
237. Epstein-Barr virus-associated B-cell proliferations of diverse clonal origins after bone marrow transplantation in a 12-year-old patient with severe combined immunodeficiency
238. Cancer after transplantation
239. Thymic origin of atypical lymphoid cells in infectious mononucleosis
240. Epstein-Barr virus in benign lymph node biopsies from individuals infected with the human immunodeficiency virus is associated with concurrent or subsequent development of non-Hodgkin's lymphoma
241. Molecular pathogenesis of AIDS-associated non-Hodgkin's lymphoma
242. Replication of Epstein-Barr virus in human epithelial cells infected in vitro
243. Epstein-Barr virus replication in oropharyngeal epithelial cells
244. A second site for Epstein-Barr virus shedding: the uterine cervix
245. Detection of a second widespread strain of Epstein-Barr virus
246. The specific induction of myc proto-oncogene expression in normal human B cells is not a sufficient event for acquisition of competence to proliferate
247. Infection surveillance in cardiac transplantation
248. Pure red cell aplasia associated with chronic Epstein-Barr virus infection: Evidence for T-cell mediated suppression of erythmoid colony forming unit
249. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy
250. Acute progressive Epstein-Barr virus infections
251. Infectious mononucleosis epidemiology and pathogenesis
252. NIH conference. Epstein-Barr virus infections: biology, pathogenesis, and management
253. Epstein-Barr virus-associated peripheral T-cell lymphoma of activated CD8 phenotype
254. Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: A clinicopathologic and molecular analysis
255. Frequent c-myc oncogene activation and infrequent presence of Epstein-Barr virus genome in AIDS associated lymphoma
256. Epstein-Barr virus DNA is amplified in transformed lymphocytes
257. Epstein-Barr virus and the X-linked lymphoproliferative syndrome
258. Case 31-1984, case records of the Massachusetts General Hospital
259. Epstein-Barr virus and lymphoproliferative disorders
260. X-linked lymphoproliferative syndrome. Natural history of the immunodeficiency
261. Epstein-Barr-virus induced lympho-proliferation. Implications for antiviral chemotherapy
262. B lymphocytopenia in infectious mononucleosis.
263. Epstein-Barr virus infectious mononucleosis in children. I. Clinical and general laboratory findings
264. Enhanced serological and virological findings of Epstein-Barr virus in patients with AIDS and AIDS-related complex
265. Detection of Epstein-Barr Viral DNA in aggressive CD8+ T cell leukaemic cells
266. Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis
267. Virologic, immunologic, and clinical observations on a patient during the incubation, acute, and convalescent phases of infectious mononucleosis
268. Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro
269. The activation antigen BLAST-2, when shed, is an autocrine BCGF for normal and transformed B cells
270. Post-transplant lymphoproliferative disorders: a morphologic, phenotypic and genotypic spectrum of diseases
271. Impairment of natural killer functions by interleukin 6 increases lymphoblastoid cell tumorigenicity in athymic mice
272. Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells.
273. Immunohistology of Epstein-Barr virus-associated antigens in B cell disorders from immunocompromised individuals
274. Epstein-Barr virus-associated lymphoproliferative disorders in immunocompromised individuals
275. Early events in EB viral infection provide a model for B cell activation
276. Generation of specific cytotoxic T cells with a fragment of the Epstein-Barr virus-encoded p63/latent membrane protein
277. Epstein-Barr virus-infected T cells in infectious mononucleosis
278. Activated lymphocytes during acute Epstein-Barr virus infection
279. The Epstein-Barr virus and the immune system
280. Cell mediated immunity
281. Interleukin-6 production in posttransplant lymphoproliferative disease
282. Abnormally elevated frequency of Epstein-Barr virus infected B cells in the blood of patients with rheumatoid arthritis
283. Severe lymphoproliferative disease and Kaposi sarcoma in transplant patients
284. Human virus-infected target cells lacking HLA antigens resist specific T-lymphocyte cytolysis
285. Apoptotic cell death of primed CD45RO+ T lymphocytes in Epstein-Barr virus-induced infectious mononucleosis
286. Fatal aplastic anemia complicating infectious mononucleosis
287. Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI
288. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells
289. Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity
290. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23
291. Suppressor T cell clones from patients with acute Epstein-Barr virus-induced infectious mononucleosis
292. Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1
293. Lymphoma in cardiac allotransplant recipients: Clinical and histological features and immunological phenotype
294. Epstein-Barr viral DNA in tissues of Hodgkin's disease
295. Detection of Epstein-Barr virus genomes in Reed-Sternberg cells of Hodgkin's disease
296. Increased frequency of posttransplant lymphomas in patients treated with cyclosporine, azathioprine, and prednisone
297. Natural history of severe thrombocytopenia in infectious mononucleosis
298. Haemolytic and other anaemias in infectious mononucleosis
299. A study of Epstein-Barr virus infections in heart and heart-lung transplant recipients
300. Burkitt's tumor in England; a comparison with childhood lymphosarcoma
301. Detection of EBV gene expression in Reed-Sternberg cells of Hodgkin's disease
302. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells
303. Airway obstruction in infectious mononucleosis
304. Detection of Epstein-Barr virus genome in benign polyclonal proliferative T cell of a young male patient
305. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease
306. Posttransplant lymphoproliferative disorders in heart-lung transplant recipients: Primary presentation in the allograft
307. Non-Hodgkin's lymphoma in 90 homosexual men: Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome
308. Persisting oncogenic herpesvirus induced by the tumour promotor TPA
309. Epstein-Barr virus lymphoproliferation after bone marrow transplantation